Sector revisions Gan & Lee Pharmaceuticals.

Equities

End-of-day quote Shanghai S.E. Other stock markets 11/12/2025			5-day change	1st Jan Change
65.27 ^CNY	+1.95%		+4.60%	+48.00%

12-09	Gan & Lee Pharmaceuticals Gets Clinical Trial Approval For Atopic Dermatitis Drug	MT
11-18	Gan & Lee Pharmaceuticals Europe GmbH Announces Committee for Medicinal Products for Human Use of the European Medicines Agency Recommends the Approval of Insulin Glargine Injection	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
GAN & LEE PHARMACEUTICALS.		2
REGENERON PHARMACEUTICALS, INC.		26
CSL LIMITED		16
UCB		18
SAMSUNG BIOLOGICS CO.,LTD.		25
BIOGEN INC.		29
INCYTE CORPORATION		21
INNOVENT BIOLOGICS, INC.		25
ALTEOGEN INC.		5
INTRA-CELLULAR THERAPIES, INC.	-	-
BRIDGEBIO PHARMA, INC.		18
SWEDISH ORPHAN BIOVITRUM AB		11
MODERNA, INC.		19
AVIDITY BIOSCIENCES, INC.		11
BIOMARIN PHARMACEUTICAL INC.		25
3SBIO INC.		11
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	1
GRIFOLS, S.A.		12
AXSOME THERAPEUTICS, INC.		20
Average		16
Weighted average by Cap.		20